Methotex 1000 mg Injection 40 ml belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis and severe psoriasis. Methotex 1000 mg Injection 40 ml is also used to treat cancer such as breast cancer, cervical cancer, bladder cancer, ovarian cancer, testicular cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), bone cancer, and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system).

Methotex 1000 mg Injection 40 ml contains 'Methotrexate' that works by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Besides this, Methotex 1000 mg Injection 40 ml prevents and stops the growth of cancer cells, thereby helps treat cancer. Methotex 1000 mg Injection 40 ml treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis.

Methotex 1000 mg Injection 40 ml will be administered by a qualified healthcare professional; do not self-administer. In some cases, Methotex 1000 mg Injection 40 ml may cause side-effects such as nausea, vomiting, diarrhoea, unusual fatigue, dizziness, headache, loss of appetite, lowered resistance to infections, tingling sensation, leukopenia (decreased number of white blood cells), and soreness of mouth and lips. You are advised to talk to your doctor if you experience any of the side effects persistently.

Do not take Methotex 1000 mg Injection 40 ml if you are pregnant or breastfeeding. Methotex 1000 mg Injection 40 ml may cause dizziness and fatigue, so avoid driving or operating machinery. Avoid consuming alcohol whilst on treatment with Methotex 1000 mg Injection 40 ml. If you are due to undergo any surgery, including dental surgery, inform the doctor that you are receiving Methotex 1000 mg Injection 40 ml. Do not have any vaccinations during treatment with Methotex 1000 mg Injection 40 ml without consulting your doctor. Inform your doctor about your medications and health condition to rule out any unpleasant side effects.

Methotex 1000 mg Injection 40 ml belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis including polyarticular juvenile rheumatoid arthritis (arthritis in children) and severe psoriasis. Methotex 1000 mg Injection 40 ml helps treat rheumatoid arthritis by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Methotex 1000 mg Injection 40 ml treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis. Methotex 1000 mg Injection 40 ml is used to treat breast cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system). Methotex 1000 mg Injection 40 ml prevents and stops the growth of cancer cells by interfering with DNA production.

Do not take Methotex 1000 mg Injection 40 ml if you are allergic to any of its contents; if you are pregnant or breastfeeding. Inform your doctor if you have immunodeficiency conditions, bone marrow problems, low white blood cell count, low platelet count, serious anaemia, liver problems due to alcohol abuse, liver, lung or kidney problems, ulceration in the stomach or bowels, poor general condition, received any vaccinations or if are due to have any, diabetes, ascites (fluid in the stomach area), lung problems or fluid in the lungs. Methotex 1000 mg Injection 40 ml may cause a serious, life-threatening reaction. If you experience symptoms such as rash, itching, hives, throat tightness, trouble swallowing, swelling of the face, throat, lips, or tongue; runny or stuffy nose, lightheadedness or dizziness, chest pain, difficulty breathing, wheezing, or feeling faint, consult your doctor immediately. Inform your doctor if you are undergoing radiation therapy; if you receive Methotex 1000 mg Injection 40 ml while you are being treated with radiation therapy for cancer, it may cause damage to the skin, bones, or other parts of the body.

• Women of child-bearing potential must use effective contraception whilst on treatment with Methotex 1000 mg Injection 40 ml and for at least 6 months after the last dose.
• If you are a male, you and your partner should use reliable contraception during treatment with Methotex 1000 mg Injection 40 ml and for at least 3 months after the last dose.
• Methotex 1000 mg Injection 40 ml may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising.
• Your doctor may advise regular blood tests, kidney and liver tests to monitor your condition.